Dr. Clayton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2955 Ivy Rd
Charlottesville, VA 22903Phone+1 434-243-4646Fax+1 434-243-4743
Education & Training
- University of Virginia Medical CenterResidency, Psychiatry, 1985 - 1988
- University of Virginia Medical CenterInternship, Transitional Year, 1982 - 1983
- University of Virginia School of MedicineClass of 1982
Certifications & Licensure
- VA State Medical License 1985 - 2026
- IL State Medical License 1983 - 1984
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response Start of enrollment: 2009 Sep 01
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 38 citationsStandards for Clinical Trials in Sexual Dysfunction in Women: Research Designs and Outcomes AssessmentAnita H. Clayton, Lorraine Dennerstein, William A. Fisher, Sheryl A. Kingsberg, Michael A. Perelman
The Journal of Sexual Medicine. 2010-01-01 - 70 citationsSexual well-being after menopause: An International Menopause Society White Paper.James A. Simon, Susan R. Davis, Stanley E. Althof, Peter Chedraui, Anita H. Clayton
Climacteric. 2018-07-10 - 55 citationsThe pathophysiology of hypoactive sexual desire disorder in womenAnita H. Clayton
International Journal of Gynaecology and Obstetrics. 2010-07-01
Press Mentions
- Zuranolone Effective in Major DepressionMay 10th, 2023
- Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) CongressOctober 4th, 2021
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Launches the Desire Project to Promote MDMA-Assisted Psychotherapy Treatment for HSDDOctober 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: